tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ipsen’s Latest Clinical Study on IPN01194: A Potential Game-Changer in Oncology
PremiumCompany AnnouncementsIpsen’s Latest Clinical Study on IPN01194: A Potential Game-Changer in Oncology
12d ago
Ipsen’s Phase II Osteosarcoma Study: A Potential Game Changer?
Premium
Company Announcements
Ipsen’s Phase II Osteosarcoma Study: A Potential Game Changer?
12d ago
Ipsen’s Real-World Study on Elafibranor for PBC: A Potential Game-Changer?
Premium
Company Announcements
Ipsen’s Real-World Study on Elafibranor for PBC: A Potential Game-Changer?
12d ago
Ipsen’s New Drug Study: A Potential Game-Changer for Advanced Solid Tumors
PremiumCompany AnnouncementsIpsen’s New Drug Study: A Potential Game-Changer for Advanced Solid Tumors
12d ago
Ipsen’s Increlex® Study: Long-term Safety and Effectiveness in Focus
Premium
Company Announcements
Ipsen’s Increlex® Study: Long-term Safety and Effectiveness in Focus
13d ago
Ipsen’s Phase III Study on Elafibranor: A Potential Game-Changer for Liver Disease Treatment
Premium
Company Announcements
Ipsen’s Phase III Study on Elafibranor: A Potential Game-Changer for Liver Disease Treatment
13d ago
Ipsen’s New Study on IPN10200: A Potential Game-Changer for Cervical Dystonia Treatment
PremiumCompany AnnouncementsIpsen’s New Study on IPN10200: A Potential Game-Changer for Cervical Dystonia Treatment
1M ago
Ipsen’s Real-World Study on Renal Cell Carcinoma Treatment: Key Update
Premium
Company Announcements
Ipsen’s Real-World Study on Renal Cell Carcinoma Treatment: Key Update
1M ago
Ipsen’s Phase III Elafibranor Study: A Potential Breakthrough in PBC Treatment
Premium
Company Announcements
Ipsen’s Phase III Elafibranor Study: A Potential Breakthrough in PBC Treatment
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100